mitotane has been researched along with 19-iodocholesterol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerman, L; Sparagana, M | 1 |
| Counsell, RE; Pohland, RC | 1 |
| Ampudia-Blasco, FJ; Bartual, AR; de Avila y Avalos, CR; Pallarés, FJ; Ruíz Hernández, G; Tenes Rodrigo, S | 1 |
3 other study(ies) available for mitotane and 19-iodocholesterol
| Article | Year |
|---|---|
Positive iodine-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal images can precede return of adrenocortical function after o,p' DDD treatment.
Topics: 19-Iodocholesterol; ACTH Syndrome, Ectopic; Adrenal Glands; Adult; Cholesterol; Humans; Iodine Radioisotopes; Male; Mitotane; Paraneoplastic Endocrine Syndromes; Radionuclide Imaging; Recurrence | 1988 |
The role of high density lipoproteins in the biodistribution of two radioiodinated probes in the rat.
Topics: 19-Iodocholesterol; Adrenal Glands; Animals; Cholesterol; Electrophoresis, Polyacrylamide Gel; Female; Injections, Intraperitoneal; Iodine Radioisotopes; Lipoproteins, HDL; Mitotane; Rats; Rats, Inbred Strains; Tissue Distribution | 1985 |
Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma.
Topics: 19-Iodocholesterol; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Agents, Hormonal; Fatal Outcome; Humans; Male; Middle Aged; Mitotane; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 1998 |